TEIPP Immunotherapy in Patients With NSCLC
Condition: Non Small Cell Lung Cancer Intervention: Drug: TEIPP24 (LRPAP7-30V-SLP vaccine in Montanide ISA-51) Sponsor: Erasmus Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Immunotherapy | Non-Small Cell Lung Cancer | Research | Vaccines